Legumain in cardiovascular disease: Culprit or ally?

Atherosclerosis. 2020 Mar:296:66-67. doi: 10.1016/j.atherosclerosis.2020.01.007. Epub 2020 Jan 23.

Authors

Saskia C de Jager¹, Imo E Hoefer²

Affiliations

¹ Laboratory for Experimental Cardiology, UMC Utrecht, Utrecht, the Netherlands.
² Central Diagnostic Laboratory, UMC Utrecht, Utrecht, the Netherlands. Electronic address: i.hoefer@umcutrecht.nl.

PMID: 32014264
DOI: 10.1016/j.atherosclerosis.2020.01.007

No abstract available

Keywords: Biomarkers; Legumain; Macrophages.

Publication types

Editorial
Comment

MeSH terms

Anti-Inflammatory Agents
Cardiovascular Diseases*
Cysteine Endopeptidases
Humans
Macrophages

Substances

Anti-Inflammatory Agents
Cysteine Endopeptidases
asparaginylendopeptidase